CORE-ABR
Sales sheet Request a demo

Pathogen

Streptococcus agalactiae

Group B streptococcus — found in urinary, genital and diabetic-foot specimens.

Also: group B strep, GBS

Gram-positive bacteriaUTI panelWound panelGraded on the antibiogram

How CORE-ABR grades it

Beta-lactams remain first line. Clindamycin and macrolide resistance through erm genes is common and is applied when detected.

What the report shows for Streptococcus agalactiae

  • Detected or not detected, with Ct, limit of detection and cycles above LOD — see PCR reporting.
  • A short pathogen summary, including colonizer likelihood where it applies.
  • A graded column on the antibiogram, and therapy options by scenario on the P.A.C.T. report.
  • When not detected, it is still listed among targets tested.

Resistance genes CORE-ABR applies

When detected, each of these genes is applied to Streptococcus agalactiae only for the agents its mechanism defeats.

ermB / ermCMLSb resistance7 organisms on paneltetB / tetMTetracycline resistance9 organisms on panel

Tagged

Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.